| FOR IMMEDIATE RELEASE |
CONTACT: James Reno
|
|
Innovation and Apexus Team Up to Provide
JOHNSON CITY, NY – January 20, 2009 – Innovation, makers of PharmASSIST® pharmacy automation solutions, today announced that the firm has signed a discounted service agreement with Apexus, the Health Resources and Services Administration’s (HRSA) awarded prime vendor for the 340B Program (PVP). The agreement enables Innovation to offer their PharmASSIST products at preferred prices to hospitals and health centers that are 340B PVP participants. The contract has been effective since October 1, 2008. “The 340B Drug Program has been a strong motivator for hospitals and health centers to improve access to outpatient pharmacy services for their eligible patient population. Whether an outpatient pharmacy processes hundreds or thousands of prescriptions daily, our cost-effective technology helps them increase capacity, optimize labor, and improve customer satisfaction and medication safety,” said John Wilson, vice president, institutional sales, Innovation. “We’re pleased that we can help our customers achieve their goals by implementing our automation solutions at preferred prices through the 340 Prime Vendor Program.” Using Innovation’s process control system (PharmASSIST Symphony) and automated dispensing technologies, outpatient pharmacies can increase the efficiency and accuracy of their prescription fulfillment process, while ensuring versatility, quality, and a clear technology growth path for future expansion. The PharmASSIST product suite is comprised of PharmASSIST Symphony® Systems (workflow and counting technology), PharmASSIST SmartScale® (counting scale), Eyecon™ (countertop counting technology), PharmASSIST SmartCabinet® (counting technology) PharmASSIST ROBOTx® (robotic dispensing), and PharmASSIST High-volume Solutions (high-volume, central fill dispensing systems). About Apexus Inc. About Innovation Associates
|
|
| BACK TO INNOVATION | |